Raymond Williams > DLA Piper LLP (US) > Philadelphia, United States > Lawyer Profile
DLA Piper LLP (US) Offices
ONE LIBERTY PLACE
1650 MARKET STREET, SUITE 5000
PHILADELPHIA, PA 19103-7300
PENNSYLVANIA
United States
- Firm Profile
- Go to...
Raymond Williams
Work Department
Litigation, Arbitration and Investigations; Life Sciences; Healthcare
Position
Senior Counsel
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
Drawing upon the expertise of ‘industry leaders who take a strategic and proactive approach to managing mass tort and related product liability litigation’, DLA Piper LLP (US) is a popular choice among life sciences clients for critical and business sensitive disputes. The firm displays ‘a very collaborative process in how they approach cases’, and is able to very effectively lead major MDLs/class actions utilizing lawyers with ‘a deep understanding of the biopharmaceutical industry’, as well as core procedural prowess. The firm has secured ‘exceptional results’ for many clients regularly securing mass tort victories at an early stage through persuasive dispositive motions, including as it relates to striking out plaintiff experts through Daubert Motions. Recognized as ‘the pre-eminent leader and authority in the mass tort, product liability and life-sciences area’, New York-based partner Loren Brown has been pivotal to many of these early successes, including his success, alongside ‘innovative thinker’ Raymond Williams , for Novo Nordisk at summary judgment in mass tort litigation involving claims that its diabetes medication Victoza causes pancreatic cancer. ‘Outstanding’ Atlanta-based product liability team head Christopher Campbell leads from the front and is noted for his ‘excellent legal skills’ and ‘co-ordination skills’, including in the context of large-scale multinational matters. Based out of Boston, Matthew Holian co-chairs the firm’s life sciences sector and regularly forms a key member of national counsel roles the firm has in complex, multi-jurisdictional product liability suits. Also based in Boston, Katie Insogna continues to impress life sciences clients and is particularly effective developing expert witnesses, on discovery matters and in relation to dispositive motions. Other key members of the team include Lucas Przymusinski , whose ‘knowledge of science and medical aspects of a case is at the cutting edge of the industry’, and Dallas-based first-chair trial lawyer Lyn Pruitt .
Lawyer Rankings
Top Tier Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Tax > International tax
- Real estate > Land use/zoning
- Investment fund formation and management > Alternative/hedge funds
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (International Trade Commission)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Government > State attorneys general
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: transactional and regulatory
- Industry focus > Cannabis
- Antitrust > Cartel
- Dispute resolution > E-discovery
- Tax > Financial products
- Finance > Fintech
- Intellectual property > Patents: litigation (full coverage)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Structured finance: securitization
- Media, technology and telecoms > Technology transactions
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- M&A/corporate and commercial > Venture capital and emerging companies
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Intellectual property > Copyright
- Environment > Environment: regulatory
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trademarks: litigation
- Tax > US taxes: non-contentious
- Finance > Capital markets: equity offerings
- Antitrust > Civil litigation/class actions: defense
- Real estate > Construction (including construction litigation)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: litigation
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Dispute resolution > International arbitration
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Finance > Project finance
- Dispute resolution > Corporate investigations and white-collar criminal defense